RN Mobile Menu


Rheumatology Network

Overactive Immune System Linked to Specific Triggers

The little-understood antibody immunoglobulin E (IgE) plays a previously unknown role in systemic lupus erythematosus, new research shows.

Recent Content

IgG4-related diseases first appeared in the medical literature in 2003, but greater awareness is needed to ensure early diagnosis.


Most patients wait an average of 74 days for a rheumatology referral in Canada, but some wait as long as three years.


Psoriatic arthritis is an independent risk factor for cardiovascular disease, according to a new meta-analysis.


A new modeling study suggests that the opioid medications tramadol and oxycodone are not generally cost-effective for knee osteoarthritis.


Patients with spondyloarthritis can confidently undergo treatment with tumor necrosis factor ⍺ inhibitors (TNFi) without fear of cancer risk.


Many new treatments for axial spondyloarthritis (SpA) have been introduced in recent years. This review summarizes current treatments for SpA.


Initial combination therapy leads to faster clinical improvements in early rheumatoid arthritis making drug-free remission a realistic outcome.

By clicking Accept, you agree to become a member of the UBM Medica Community.